Document is current
Any future updates will be listed below
-
Authors
Rohde, Monica M.
Snyder, Christina M.
Sloop, John
Solst, Shane R.
Donati, George L.
Spitz, Douglas R.
Furdui, Cristina M.
Singh, Ravi https://orcid.org/0000-0003-0750-1804
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA207222)
National Cancer Institute (R33CA177461)
National Cancer Institute (P01CA217797)
National Cancer Institute (R01CA18280)
National Cancer Institute (P30CA012197)
National Cancer Institute (P30CA086862)
National Institute of General Medical Sciences (T32GM127261)
- License Information
-
More Information
Article History
Received: 17 April 2021
Accepted: 21 September 2021
First Online: 14 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: RS has filed for protection of intellectual property relating to molecular signatures predictive of cancer sensitivity to silver nanoparticles (WO 2018/231790 Al). CMF is co-founder of Xoder Technologies, LLC, which provides consulting services and commercializes reagents for redox investigations.
